EBV-Positive Mucocutaneous Ulcer
1 clinical trials · Condition
◉ Watch EBV-Positive Mucocutaneous Ulcer
| Record | Firm | Date |
|---|---|---|
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
Track EBV-Positive Mucocutaneous Ulcer automatically
Every clearance here is in the API, with alerts when new ones post.